. 2024 Jan 1;20(2):516–536. doi: 10.7150/ijbs.84399

Table 3.

Correlation between expression of p32 and DLAT and clinicopathologic characteristics in ccRCC patients

		N	DLAT expression		p value	p32 expression		p value
		N	-	+	p value	-	+	p value
Gender	Male	54	44	10	0.34	37	17	0.131
Gender	Female	21	19	2	0.34	18	3	0.131
Age	<60	30	23	7	0.157	20	10	0.286
Age	≥60	45	40	5	0.157	35	10	0.286
Tumor size	<4	16	15	1	0.459	11	5	0.895
	>4,≤7	24	20	4		18	6
	>7	35	28	7		26	9
T stage	T1-2	46	37	9	0.289	28	18	0.002**
T stage	T3-4	29	26	3	0.289	27	2	0.002**
Fuhrman grade	I,II	39	31	8	0.267	24	15	0.016*
Fuhrman grade	III,IV	36	32	4	0.267	31	5	0.016*
Location	Tumor	75	63	12	<0.001***	55	20	<0.001***
Location	Para-tumor	75	11	64	<0.001***	10	65	<0.001***

Note: IHC staining results (+): positive, (-): negative. Pearson's X² tests were used. The results were considered statistically significant at P < 0.05. *P < 0.05, **P < 0.01, ***P < 0.001.